286 related articles for article (PubMed ID: 17105590)
1. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma.
Kisaka Y; Hirooka M; Koizumi Y; Abe M; Matsuura B; Hiasa Y; Onji M
J Clin Ultrasound; 2010; 38(3):138-44. PubMed ID: 20014137
[TBL] [Abstract][Full Text] [Related]
3. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
[TBL] [Abstract][Full Text] [Related]
4. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
[TBL] [Abstract][Full Text] [Related]
5. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
6. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
[TBL] [Abstract][Full Text] [Related]
8. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
10. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
[TBL] [Abstract][Full Text] [Related]
11. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
[No Abstract] [Full Text] [Related]
12. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
13. The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular Carcinoma.
Liu Z; Wang X; Xing L; Pan Y; Huang S
Cancer Biother Radiopharm; 2019 Dec; 34(10):621-625. PubMed ID: 31809215
[No Abstract] [Full Text] [Related]
14. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation.
Ishii T; Numata K; Hao Y; Doba N; Hara K; Kondo M; Tanaka K; Maeda S
Eur J Radiol; 2017 Apr; 89():234-241. PubMed ID: 28034569
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT.
Salvaggio G; Campisi A; Lo Greco V; Cannella I; Meloni MF; Caruso G
Abdom Imaging; 2010 Aug; 35(4):447-53. PubMed ID: 19562414
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography.
Kim AY; Lee MW; Rhim H; Cha DI; Choi D; Kim YS; Lim HK; Cho SW
Korean J Radiol; 2013; 14(5):754-63. PubMed ID: 24043968
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
[TBL] [Abstract][Full Text] [Related]
18. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging.
Minami T; Minami Y; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Inoue T; Hagiwara S; Ueshima K; Nishida N; Kudo M
Oncology; 2014; 87 Suppl 1():55-62. PubMed ID: 25427734
[TBL] [Abstract][Full Text] [Related]
19. The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy.
Chen MH; Wu W; Yang W; Dai Y; Gao W; Yin SS; Yan K
J Ultrasound Med; 2007 Aug; 26(8):1055-63. PubMed ID: 17646367
[TBL] [Abstract][Full Text] [Related]
20. Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings.
Cao J; Dong Y; Mao F; Wang W
Biomed Res Int; 2018; 2018():6469703. PubMed ID: 30225261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
